Bridge Biotherapeutics (Korea) Price History

288330 Stock  KRW 3,940  120.00  2.96%   
If you're considering investing in Bridge Stock, it is important to understand the factors that can impact its price. As of today, the current price of Bridge Biotherapeutics stands at 3,940, as last reported on the 23rd of December, with the highest price reaching 4,150 and the lowest price hitting 3,720 during the day. Bridge Biotherapeutics appears to be very steady, given 3 months investment horizon. Bridge Biotherapeutics secures Sharpe Ratio (or Efficiency) of 0.0279, which signifies that the company had a 0.0279% return per unit of risk over the last 3 months. We have found thirty technical indicators for Bridge Biotherapeutics, which you can use to evaluate the volatility of the firm. Please makes use of Bridge Biotherapeutics' Mean Deviation of 5.78, downside deviation of 6.03, and Risk Adjusted Performance of 0.0349 to double-check if our risk estimates are consistent with your expectations.
  
Bridge Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0279

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns288330
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 8.13
  actual daily
72
72% of assets are less volatile

Expected Return

 0.23
  actual daily
4
96% of assets have higher returns

Risk-Adjusted Return

 0.03
  actual daily
2
98% of assets perform better
Based on monthly moving average Bridge Biotherapeutics is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bridge Biotherapeutics by adding it to a well-diversified portfolio.

Bridge Biotherapeutics Stock Price History Chart

There are several ways to analyze Bridge Stock price data. The simplest method is using a basic Bridge candlestick price chart, which shows Bridge Biotherapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceOctober 21, 20245850.0
Lowest PriceDecember 9, 20242660.0

Bridge Biotherapeutics December 23, 2024 Stock Price Synopsis

Various analyses of Bridge Biotherapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Bridge Stock. It can be used to describe the percentage change in the price of Bridge Biotherapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Bridge Stock.
Bridge Biotherapeutics Price Daily Balance Of Power(0.28)
Bridge Biotherapeutics Price Action Indicator(55.00)
Bridge Biotherapeutics Price Rate Of Daily Change 0.97 

Bridge Biotherapeutics December 23, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Bridge Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Bridge Biotherapeutics intraday prices and daily technical indicators to check the level of noise trading in Bridge Stock and then apply it to test your longer-term investment strategies against Bridge.

Bridge Stock Price History Data

The price series of Bridge Biotherapeutics for the period between Tue, Sep 24, 2024 and Mon, Dec 23, 2024 has a statistical range of 3190.0 with a coefficient of variation of 22.44. The prices are distributed with arithmetic mean of 4017.58. The median price for the last 90 days is 3995.0. The company had 1:1 stock split on 29th of July 2024.
OpenHighLowCloseVolume
12/23/2024
 3,960  4,150  3,720  3,940 
12/20/2024 3,960  4,150  3,720  3,940  2,011,576 
12/19/2024 4,350  4,530  4,015  4,060  2,793,754 
12/18/2024 4,755  4,950  4,325  4,600  3,165,349 
12/17/2024 3,825  4,965  3,790  4,955  6,842,621 
12/16/2024 3,120  3,950  3,105  3,820  5,589,848 
12/13/2024 3,100  3,170  2,940  3,060  541,411 
12/12/2024 2,980  3,150  2,980  3,135  515,084 
12/11/2024 2,985  3,075  2,900  3,025  695,295 
12/10/2024 2,685  2,975  2,685  2,955  530,783 
12/09/2024 2,745  2,865  2,610  2,660  708,936 
12/06/2024 2,910  3,085  2,720  2,885  1,081,032 
12/05/2024 3,080  3,080  2,810  2,960  813,020 
12/04/2024 3,365  3,370  2,970  3,045  2,127,994 
12/03/2024 2,900  3,530  2,895  3,455  1,407,806 
12/02/2024 3,320  3,330  2,950  3,025  976,485 
11/29/2024 3,600  3,600  3,250  3,310  901,166 
11/28/2024 3,245  3,520  3,210  3,520  757,850 
11/27/2024 3,425  3,470  3,110  3,240  892,001 
11/26/2024 3,460  3,460  3,240  3,390  729,230 
11/25/2024 3,135  3,535  3,115  3,365  1,335,220 
11/22/2024 3,150  3,330  2,975  3,020  848,002 
11/21/2024 3,040  3,125  2,750  3,075  940,876 
11/20/2024 2,845  3,135  2,740  3,030  1,325,396 
11/19/2024 2,740  2,845  2,550  2,845  1,185,565 
11/18/2024 2,915  2,990  2,715  2,775  840,361 
11/15/2024 2,950  3,035  2,830  3,005  695,290 
11/14/2024 3,290  3,290  3,005  3,050  717,266 
11/13/2024 3,525  3,530  2,955  3,170  1,714,177 
11/12/2024 3,290  3,690  3,230  3,520  2,488,084 
11/11/2024 3,345  3,400  3,180  3,225  1,108,070 
11/08/2024 3,465  3,540  3,280  3,340  1,497,438 
11/07/2024 3,890  3,890  3,300  3,465  2,520,172 
11/06/2024 4,200  4,280  3,780  3,890  2,105,160 
11/05/2024 4,510  4,590  4,115  4,200  807,699 
11/04/2024 4,115  4,575  3,990  4,500  1,581,870 
11/01/2024 4,420  4,465  4,050  4,115  1,866,435 
10/31/2024 4,655  4,795  4,320  4,500  718,696 
10/30/2024 4,540  4,725  4,195  4,645  895,871 
10/29/2024 4,990  5,020  4,430  4,575  2,188,966 
10/28/2024 5,140  5,370  4,980  4,980  740,466 
10/25/2024 5,250  5,290  5,030  5,090  643,620 
10/24/2024 5,220  5,380  4,985  5,290  1,139,614 
10/23/2024 5,830  5,900  4,995  5,220  3,197,333 
10/22/2024 5,790  6,070  5,760  5,790  1,521,569 
10/21/2024 5,750  6,050  5,600  5,850  1,853,140 
10/18/2024 5,710  6,000  5,480  5,730  1,409,047 
10/17/2024 5,750  6,100  5,520  5,740  2,785,607 
10/16/2024 5,740  5,940  5,590  5,640  1,967,664 
10/15/2024 4,940  5,840  4,900  5,690  4,736,468 
10/14/2024 5,170  5,280  4,900  4,975  1,575,401 
10/11/2024 4,785  5,340  4,675  5,250  2,470,696 
10/10/2024 5,060  5,070  4,665  4,820  1,681,576 
10/08/2024 4,670  5,010  4,580  4,835  1,902,480 
10/07/2024 4,565  5,370  4,555  4,840  6,543,322 
10/04/2024 4,175  4,450  4,070  4,435  1,388,850 
10/02/2024 3,930  4,230  3,865  4,175  1,383,964 
09/30/2024 3,855  4,040  3,680  3,895  775,964 
09/27/2024 4,040  4,085  3,805  3,860  784,165 
09/26/2024 3,980  4,085  3,960  4,015  450,835 
09/25/2024 4,190  4,260  3,970  3,995  669,572 

About Bridge Biotherapeutics Stock history

Bridge Biotherapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Bridge is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Bridge Biotherapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Bridge Biotherapeutics stock prices may prove useful in developing a viable investing in Bridge Biotherapeutics
Bridge Biotherapeutics, Inc., a clinical stage biotech company, engages in the development of therapeutics for the treatment of ulcerative colitis, fibrotic diseases, and cancers worldwide. The company was founded in 2015 and is headquartered in Seongnam, Korea. BRIDGE BIOTHERAPEUTICS is traded on Korean Securities Dealers Automated Quotations in South Korea.

Bridge Biotherapeutics Stock Technical Analysis

Bridge Biotherapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Bridge Biotherapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Bridge Biotherapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio Comparator Now

   

Portfolio Comparator

Compare the composition, asset allocations and performance of any two portfolios in your account
All  Next Launch Module

Bridge Biotherapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Bridge Biotherapeutics' price direction in advance. Along with the technical and fundamental analysis of Bridge Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Bridge to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Bridge Stock analysis

When running Bridge Biotherapeutics' price analysis, check to measure Bridge Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bridge Biotherapeutics is operating at the current time. Most of Bridge Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Bridge Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bridge Biotherapeutics' price. Additionally, you may evaluate how the addition of Bridge Biotherapeutics to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets